Evaluation of Access to Licensed Vaccines for High-Risk Infectious Diseases: A Comprehensive Review and Interpretive Analysis of Ebola Virus Disease - Top-Institutions - MDSpire

Evaluation of Access to Licensed Vaccines for High-Risk Infectious Diseases: A Comprehensive Review and Interpretive Analysis of Ebola Virus Disease

  • By

  • Charlot Diepvens

  • Donovan Guttieres

  • Kim De Boeck

  • Nico Vandaele

  • Leonor Guariguata

  • Catherine Decouttere

  • January 10, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #2

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Vaccine Development
    • Infectious Diseases

  • #3

    World Health Organization (WHO) Collaborating Centers for Emerging Infectious Diseases
    World Health Organization (WHO) Collaborating Centers for Emerging Infectious Diseases

    Geneva, Switzerland

    Key Differentiators

    • Global Health
    • Infectious Disease Control
    • Vaccine Access

  • #4

    Institut National de Recherche Biomédicale (INRB)
    Institut National de Recherche Biomédicale (INRB)

    Kinshasa, DR Congo

    Key Differentiators

    • Infectious Diseases
    • Field Epidemiology
    • Vaccine Trials

  • #5

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Global Health
    • Vaccine Policy

Original Source(s)

Evaluation of Access to Licensed Vaccines for High-Risk Infectious Diseases: A Comprehensive Review and Interpretive Analysis of Ebola Virus Disease

  • by Charlot Diepvens, Donovan Guttieres, Kim De Boeck, Nico Vandaele, Leonor Guariguata, Catherine Decouttere

  • January 10, 2026

Related Content

First hantavirus, now Ebola: What two outbreaks reveal about global preparedness

Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study

HPV Vaccine Uptake Varied Widely Across US States

Analysis of more than 16,000 US adolescents found substantial variation in HPV vaccination uptake both across and within census regions